Agreement will add iconic supplement brands to cbdMD's growing multi-brand consumer wellness platform, anticipated to increase revenues to approximately $30 million.

该协议将为cbdMD日益壮大的多品牌消费者健康平台增添标志性的补充剂品牌，预计收入将增至约3,000万美元。

CHARLOTTE, N.C.

北卡罗来纳州，夏洛特

,

，

Sept. 2, 2026

2026年9月2日

/PRNewswire/ -- cbdMD, Inc. (NYSE American:

/美通社/ -- cbdMD, Inc.（纽约证券交易所美国市场：

YCBD

YCBD

), a leading consumer wellness company, today announced that it has entered into a definitive asset purchase agreement to acquire operating assets and brands of Twinlab, including Twinlab, Reserveage, Metabolife, and Alvita Tea. The acquisition is being conducted through an assignment for the benefit of creditors (ABC) proceeding and is subject to court approval and customary closing conditions..

），一家领先的消费者健康公司，今日宣布已签署具有约束力的资产购买协议，以收购Twinlab的运营资产及品牌，包括Twinlab、Reserveage、Metabolife和Alvita Tea。此次收购将通过债权人利益转让（ABC）程序进行，并须获得法院批准及满足惯例交割条件。

The transaction is expected to give the acquired brands a stable home and provide an orderly path forward for the business's legacy obligations, allowing the brands, their products, and their customer relationships to continue uninterrupted. For customers, retailers, and distribution partners, it means the products they rely on will remain available and are backed by a company committed to investing in them for the long term..

此次交易预计将为被收购品牌提供一个稳定的归属，并为其历史义务提供有序的解决路径，确保品牌、产品及其客户关系能够持续 uninterrupted。对于客户、零售商和分销合作伙伴而言，这意味着他们所依赖的产品将继续供应，并由一家致力于长期投资的公司提供支持。

This transaction is expected to reduce cbdMD's revenue concentration in the hemp category and mitigate risks associated with the evolving regulatory environment for hemp-derived products. Based on unaudited financial information, the combined unaudited trailing twelve months of revenue ending June 2026 totals approximately $30 million, which would represent an increase of approximately 40% relative to cbdMD's standalone revenue for the same period.

此次交易预计将降低 cbdMD 在大麻品类中的收入集中度，并缓解与大麻衍生产品监管环境变化相关的风险。根据未经审计的财务信息，截至 2026 年 6 月的过去十二个月合并未经审计收入总额约为 3,000 万美元，较 cbdMD 同期独立收入增长约 40%。

The incremental revenue is expected to generate positive contribution after transaction and integration costs. This combined revenue figure is provided for illustrative purposes only and should not be viewed as indicative of future results..

预计增量收入在扣除交易和整合成本后将产生正向贡献。该合并收入数据仅为 illustrative 目的提供，不应被视为对未来业绩的预示。

The transaction marks a significant step in cbdMD's evolution into a broader multi-brand consumer wellness platform spanning supplements, sports nutrition, longevity, functional wellness, pet wellness, hemp-derived products, and adjacent consumer health categories. As the platform grows beyond its origins in CBD and hemp, the Company expects its identity to evolve to reflect the full breadth of consumer wellness it now serves..

此次交易标志着cbdMD向更广泛的多品牌消费健康平台转型的重要一步，该平台涵盖膳食补充剂、运动营养、长寿科技、功能健康、宠物健康、大麻衍生产品以及相邻的消费健康品类。随着平台业务超越其CBD和大麻起源，公司预计其品牌身份将随之演变，以反映其目前所服务的消费健康领域的全面广度。

Founded in 1968, Twinlab is one of the most recognized names in legacy supplements and sports nutrition, bringing decades of consumer recognition, category credibility, retail relevance in serving 50,000 retail outlets, including Vitamin Shop and GNC in addition to a strong Amazon presence, and product heritage across vitamins, minerals, active lifestyle, beauty and performance nutrition..

Twinlab 成立于 1968 年，是传统膳食补充剂和运动营养领域最具知名度的品牌之一。凭借数十年来积累的消费者认知、品类信誉和零售影响力，Twinlab 服务于包括 Vitamin Shoppe 和 GNC 在内的 50,000 家零售门店，并在亚马逊平台上拥有强大的市场存在感。其产品传承涵盖维生素、矿物质、活跃生活方式、美容以及性能营养等多个领域。

'Twinlab is the kind of brand equity that companies spend decades trying to build,' said Ronan Kennedy, CEO of cbdMD. 'The brands, distribution channels, and team are highly complementary to what we already operate, and this transaction gives these brands the stability and support they need for their next chapter.

“Twinlab 是那种企业耗费数十年力求打造的品牌资产，”cbdMD 首席执行官罗南·肯尼迪表示。“这些品牌、分销渠道和团队与我们现有业务高度互补，此次交易将为这些品牌迈向下一阶段提供所需的稳定性和支持。”

We believe there is a significant opportunity to build on cbdMD's revenue growth by applying our marketing, creative, and ecommerce resources to drive brand awareness and expand direct-to-consumer sales, alongside the strong wholesale and retail presence these brands already have. From the fundamentals of nutrition to the frontier of modern wellness, the combined portfolio is a unique offering in consumer wellness.'.

我们相信，通过运用我们的营销、创意和电子商务资源来提升品牌知名度并扩大直接面向消费者的销售，同时依托这些品牌已有的强大批发和零售布局，cbdMD 的收入增长将拥有显著的提升空间。从营养基础到现代健康前沿，合并后的产品组合在消费者健康领域提供了独特的价值主张。

'cbdMD is the right home for these brands,' said Anthony Zolezzi, Chief Executive Officer of Twinlab. 'Together, we will bring a uniquely complete wellness portfolio spanning foundational vitamins, minerals, and nutrition through botanicals, beauty, longevity, functional mushrooms, cannabinoids, and the emerging breakthroughs defining where this industry is headed.

“cbdMD 是这些品牌的理想归属，”Twinlab 首席执行官安东尼·佐莱齐表示。“我们将携手打造一个独具特色的全面健康产品组合，涵盖基础维生素、矿物质和营养补充剂，并延伸至植物萃取、美容护肤、长寿科技、功能性蘑菇、大麻素以及定义行业未来发展方向的新兴突破领域。”

We believe no other company can serve consumers across more needs, more moments, and more stages of life than we now can together. This combination will pair decades of heritage and category credibility with a modern, marketing-driven platform and the resources to reintroduce these products to a new generation of consumers.

我们相信，没有任何其他公司能像我们如今这样，共同满足消费者在更多需求、更多场景以及更多人生阶段中的需要。此次合并将把数十年的品牌传承与品类信誉，与现代营销驱动的平台及资源相结合，从而将这些产品重新推向新一代消费者。

It positions the brands, and the people behind them, for a strong future.' .

它为这些品牌及其背后的团队奠定了通向强劲未来的基础。

Upon closing of the acquisition the acquired portfolio will expand cbdMD's reach into additional consumer need states, including daily wellness, active lifestyle, weight management, longevity, recovery, beauty and functional supplementation. Reserveage brings premium longevity, resveratrol, collagen, and beauty-from-within positioning; Metabolife will bring established weight management brand recognition products..

在完成收购后，所收购的产品组合将扩大cbdMD在更多消费者需求场景中的覆盖范围，包括日常健康、活跃生活方式、体重管理、长寿、恢复、美容和功能性补充剂。Reserveage带来高端的长寿、白藜芦醇、胶原蛋白以及“由内而外的美容”定位；Metabolife则将带来具有成熟市场认知度的体重管理品牌产品。

The agreement follows cbdMD's earlier acquisition and integration of Bluebird Botanicals and reflects the Company's continued strategy of building a portfolio of trusted wellness brands that benefit from shared infrastructure, operational alignment, product innovation, and modern commerce execution..

该协议紧随cbdMD此前对Bluebird Botanicals的收购与整合，体现了公司持续打造值得信赖的健康品牌组合的战略，这些品牌将受益于共享基础设施、运营协同、产品创新以及现代商业执行。

In connection with entering into the agreement, cbdMD has filed a Current Report on Form 8-K with the Securities and Exchange Commission, which includes additional details regarding the transaction and conditions for closing.

为签署该协议，cbdMD已向美国证券交易委员会提交了8-K表格的当前报告，其中包含有关交易及交割条件的更多详细信息。

About cbdMD, Inc.

关于 cbdMD 公司

cbdMD, Inc. is a consumer wellness company focused on building a multi-brand platform across CBD, hemp-derived wellness, pet wellness, botanical wellness, supplements, longevity, functional wellness, and related consumer health categories. The Company's portfolio includes cbdMD, Paw CBD, Oasis, Bluebird Botanicals.

cbdMD, Inc. 是一家专注于打造跨品类多品牌平台的消费者健康公司，业务涵盖CBD（大麻二酚）、源自大麻的健康产品、宠物健康、植物健康、膳食补充剂、长寿科技、功能性健康及相关消费健康领域。公司产品组合包括 cbdMD、Paw CBD、Oasis 和 Bluebird Botanicals。

The Company is focused on quality, transparency, compliance, consumer trust, product innovation, ecommerce, wholesale, retail support, and the development of a broader wellness platform serving multiple consumer needs. For more information, visit .

公司专注于质量、透明度、合规性、消费者信任、产品创新、电子商务、批发、零售支持，以及开发服务于多种消费者需求的更广泛健康平台。欲了解更多信息，请访问。

www.cbdmd.com

www.cbdmd.com

.

。

About Twinlab

关于 Twinlab

Founded in 1968, Twinlab is a heritage leader in nutritional supplements and sports nutrition, with a decades-long reputation for quality and innovation across vitamins, minerals, amino acids, and performance nutrition. The Twinlab family of brands includes Reserveage, a premium longevity and beauty-from-within brand known for its resveratrol, collagen, and healthy-aging products; Metabolife, a recognized name in weight management and Rip Fuel for performance Sports.

Twinlab 成立于 1968 年，是营养补充剂和运动营养领域的传承领导者，凭借在维生素、矿物质、氨基酸和表现营养方面数十年的质量与创新声誉而闻名。Twinlab 旗下品牌家族包括 Reserveage，这是一个主打长寿与内在美容的高端品牌，以其白藜芦醇、胶原蛋白和健康衰老产品而著称；还包括 Metabolife，这是体重管理领域的知名品牌，以及专为运动表现打造的 Rip Fuel。

Together, these brands have built lasting consumer trust and broad distribution across retail, wholesale, and ecommerce channels..

这些品牌共同建立了持久的消费者信任，并在零售、批发和电子商务渠道中实现了广泛的分销。

Forward-Looking Statements

前瞻性陈述

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements include, but are not limited to, statements regarding the proposed acquisition, expected revenues, revenue increases, the ability to obtain court approval and complete the transaction, integration plans, brand portfolio development, product availability, and ecommerce.

本新闻稿包含《1933年证券法》第27A条和《1934年证券交易法》第21E条所定义的“前瞻性陈述”。这些前瞻性陈述包括但不限于以下方面的陈述：拟议的收购、预期收入、收入增长、获得法院批准并完成交易的能力、整合计划、品牌组合发展、产品供应情况以及电子商务。

These statements are based on management's current expectations, estimates, and projections and are subject to significant risks and uncertainties that could cause actual results to differ materially from those anticipated. Such risks include, but are not limited to, court approval of the ABC and complete the transaction on the anticipated terms or timeline, satisfy closing conditions, successfully integrate acquired assets and brands, retain key employees and business relationships, maintain wholesale and retail relationships, execute ecommerce and marketplace strategies, develop new product categories, achieve anticipated operational efficiencies and cost savings, manage costs and capital requirements, maintain regulatory compliance across all product categories, access capital on favorable terms, the risk that the unaudited financial information regarding the acquired brands is inaccurate or that audited financial statements meeting the requirements of Regulation S-X cannot be timely obtained, and other risks described in the Company's filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q.

这些陈述基于管理层当前的预期、估计和预测，并受重大风险和不确定性的影响，可能导致实际结果与预期存在重大差异。此类风险包括但不限于：获得法院对ABC方案的批准并按预期的条款或时间表完成交易；满足交割条件；成功整合收购的资产和品牌；保留关键员工和业务关系；维持批发和零售合作关系；执行电子商务和市场平台战略；开发新产品类别；实现预期的运营效率和成本节约；管理成本和资本需求；在所有产品类别中保持监管合规；以有利条件获取资本；有关收购品牌的未经审计财务信息不准确的风险，或无法及时获得符合S-X条例要求的经审计财务报表的风险；以及公司在美国证券交易委员会（SEC）文件中描述的其他风险，包括其最新的10-K表格年度报告和后续的10-Q表格季度报告。

Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the.

提醒读者不要过度依赖这些前瞻性陈述，它们仅在作出之日有效。

Contacts

联系人

Investors:

投资者：

cbdMD, Inc.

cbdMD 公司

Ronan Kennedy

罗南·肯尼迪

Chief Executive Officer and Chief Financial Officer

首席执行官兼首席财务官

[email protected]

[email protected]

(704) 445-3064

(704) 445-3064

SOURCE cbdMD, Inc.

来源：cbdMD, Inc.

21

二十一

%

%

more press release views with

更多新闻稿浏览量，通过

Request a Demo

申请演示